These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1440326)

  • 21. [Morphology and biochemical parameters of the regression of carotid artery lesions].
    Hennerici M; Steinke W
    Vasa Suppl; 1987; 20():77-84. PubMed ID: 3480609
    [No Abstract]   [Full Text] [Related]  

  • 22. Correlation of coronary artery atherosclerosis with atherosclerosis of the intracranial cerebral artery and the extracranial carotid artery.
    Seo WK; Yong HS; Koh SB; Suh SI; Kim JH; Yu SW; Lee JY
    Eur Neurol; 2008; 59(6):292-8. PubMed ID: 18408369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vascular symptoms are not confined to the legs. Peripheral arterial occlusive disease especially threatens the diabetic heart].
    MMW Fortschr Med; 2004 Aug; 146(31-32):48. PubMed ID: 15529714
    [No Abstract]   [Full Text] [Related]  

  • 24. The year in atherothrombosis.
    Sanz J; Moreno PR; Fuster V
    J Am Coll Cardiol; 2010 Apr; 55(14):1487-98. PubMed ID: 20359599
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost-effectiveness analysis in diagnosis of coronary artery disease: choice of laboratory markers.
    Bogavac-Stanojević N; Ivanova Petrova G; Jelić-Ivanović Z; Memon L; Spasić S
    Clin Biochem; 2007 Nov; 40(16-17):1180-7. PubMed ID: 17869234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interrelation of coronary and cerebral arteriosclerosis.
    Kovárová M
    Acta Univ Palacki Olomuc Fac Med; 1991; 130():233-40. PubMed ID: 1838872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Lipoprotein(a) [Lp(a)]--a genetically related risk factor for arteriosclerosis].
    Feussner G; Feussner V; Ziegler R
    Med Klin (Munich); 1994 Apr; 89(4):198-203. PubMed ID: 8015535
    [No Abstract]   [Full Text] [Related]  

  • 28. [Types of arteriosclerosis and their diagnosis in general practice].
    Rau G
    Z Allgemeinmed; 1974 Jul; 50(21):940-8. PubMed ID: 4850051
    [No Abstract]   [Full Text] [Related]  

  • 29. [Differential use of apolipoproteins and lipoproteins as discriminators for atherogenic risk].
    Mertz DP; Göhmann E; Ostertag J
    Med Welt; 1981 Oct; 32(43):1611-5. PubMed ID: 7300661
    [No Abstract]   [Full Text] [Related]  

  • 30. [The clinical instrumental evaluation of treatment efficacy in patients with concomitant atherosclerosis of the coronary, cerebral and peripheral arteries].
    Karpov RS; Dudko VA; Shipulin VM; Kanskaia NV; Koshel'skaia OA; Stepanian NA; Fedorova NA; Balabanova AV
    Ter Arkh; 1991; 63(4):90-3. PubMed ID: 2068687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipids, atherosclerosis and risk factors.
    Mehta PJ; Kamath SA; Hakim A
    J Assoc Physicians India; 1993 Jul; 41(7):411. PubMed ID: 8300480
    [No Abstract]   [Full Text] [Related]  

  • 32. [Combined forms of arteriosclerotic lesions of the coronary and major arteries: characteristics of their diagnosis and treatment].
    Karpov RS
    Klin Med (Mosk); 1991 Jan; 69(1):8-12. PubMed ID: 2023405
    [No Abstract]   [Full Text] [Related]  

  • 33. [Apolipoproteins in atherosclerosis].
    Carino C; Rauseo R; Tiboni GM; De Martiis M
    Clin Ter; 1984 Sep; 110(5):477-82. PubMed ID: 6238762
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lipoprotein (a): variability and association with coronary disease].
    Souza DR; Garcia MV
    Arq Bras Cardiol; 1994 Mar; 62(3):187-94. PubMed ID: 7980082
    [No Abstract]   [Full Text] [Related]  

  • 35. [Characteristics of apolipoprotein polymorphism in a Hungarian population].
    Császár A
    Orv Hetil; 1997 Sep; 138(36 Suppl 2):2296-7. PubMed ID: 9340574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genetic factors in ischemic heart disease].
    Slavchev S
    Vutr Boles; 1986; 25(3):12-9. PubMed ID: 3532554
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relation of serum apolipoprotein and lipoprotein and coronary atherosclerosis].
    Morimoto S; Hiasa Y; Maeda T; Harada M; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H
    Kokyu To Junkan; 1986 Nov; 34(11):1221-6. PubMed ID: 3809751
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determination of apolipoproteins AI and B: diagnostic significance and immunochemical methods].
    Marcovina S
    Ric Clin Lab; 1984; 14 Suppl 2():75-94. PubMed ID: 6442453
    [No Abstract]   [Full Text] [Related]  

  • 39. [The cholesterol content in immune complexes as a marker of coronary and peripheral atherosclerosis].
    Kalenich OS; Tertov VV; Liakishev AA; Ruda MIa; Orekhov AN
    Ter Arkh; 1991; 63(9):59-61. PubMed ID: 1759226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Apolipoproteins A and B in cerebrovascular diseases].
    Bruck J; Fischer M; Sluga E; Tschabitscher H
    Nervenarzt; 1985 Feb; 56(2):89-93. PubMed ID: 3982568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.